Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects [Retraction]
Vinson JA, Burnham BR, Nagendran MV. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2012;5:21–27. The sponsors of the study cannot assure the validity of the data so we, Joe Vinson and Bryan Burnham, are retracting the paper. This retraction relates to th...
Guardado en:
Autores principales: | Vinson JA, Burnham BR, Nagendran MV |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a21d625f2cdc49c9b61ccdd53cc94197 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
por: Vinson JA, et al.
Publicado: (2012) -
Effects of Phyllanthus amarus PHYLLPROTM leaves on hangover symptoms: a randomized, double-blind, placebo-controlled crossover study
por: Annie George, et al.
Publicado: (2019) -
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults
por: Ermer J, et al.
Publicado: (2013) -
Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trial.
por: Martin de Bock, et al.
Publicado: (2012) -
Acute Metabolic Responses to Glucose and Fructose Supplementation in Healthy Individuals: A Double-Blind Randomized Crossover Placebo-Controlled Trial
por: Max L. Eckstein, et al.
Publicado: (2021)